(1996) reported the analog was 1.5-2x more potent than equimolar IGF-1 in catabolic rat models, and broader pharmacology literature places it at roughly 3x potency overall
dividing by the 2mL volume yields a concentration of 5,000mcg/mL, or 5mcg per 0.001mL (1 microliter) drawn
The placebo effect is powerful, especially with expensive, highly anticipated compounds
In controlled research environments, GHK-Cu is commonly used to study: Skin and connective-tissue repair processes Fibroblast recruitment, proliferation, and matrix production Angiogenesis and endothelial-cell behavior Antimicrobial activity in wound models (when combined with selected co-factors) Neurobiological and gene-expression changes in nervous system models Experimental modulation of inflammatory and fibrotic responses These applications make GHK-Cu a versatile tool for probing how small copper-peptide complexes participate in tissue-regeneration and stress-response pathways
offers PT-141 Peptide Therapy to Baltimore men in a safe, caring, compassionate and judgement free environment